| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.0B | $33.0B | $32.9B | $33.4B | $30.8B | $27.2B | $7.1B | $5.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| SG&A Expense | $3.4B | $3.3B | $3.3B | $3.1B | $3.2B | $3.2B | $3.5B | $1.6B |
| Operating Income | $8.9B | $8.6B | $8.0B | $5.4B | $5.0B | $3.3B | $0.7B | $3.2B |
| Net Income | $6.9B | $6.6B | $6.2B | $4.1B | $3.8B | $2.5B | $0.5B | $3.0B |
| EPS (Basic) | $14.69 | $13.71 | $12.70 | $8.30 | $7.40 | $4.75 | $4.22 | $13.26 |
| EPS (Diluted) | $14.61 | $13.62 | $12.59 | $8.23 | $7.33 | $4.71 | $4.19 | $13.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $86.8B | $80.1B | $80.8B | $79.7B | $81.6B | $88.2B | $86.6B | $93.4B |
| Current Assets | $13.3B | $12.9B | $12.6B | $13.0B | $10.2B | $10.9B | $10.4B | $17.3B |
| Cash & Equivalents | $5.1B | $4.8B | $4.7B | $5.4B | $2.8B | $3.8B | $2.7B | $4.5B |
| Total Liabilities | $47.1B | $40.7B | $39.7B | $38.3B | $36.2B | $38.6B | $35.0B | $36.3B |
| Current Liabilities | $15.2B | $14.5B | $15.7B | $16.5B | $13.6B | $13.7B | $12.2B | $13.0B |
| Stockholders' Equity | $38.2B | $38.1B | $39.7B | $40.0B | $44.0B | $47.3B | $49.1B | $51.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.3B | $9.4B | $9.3B | $8.9B | — | — | — | — |
| Investing Cash Flow | $-5.7B | $-4.6B | $-4.7B | $-3.1B | — | — | — | $5.4B |
| Capital Expenditures | $5.3B | $4.5B | $3.8B | $3.2B | $3.1B | $3.4B | $3.7B | $1.9B |
| Financing Cash Flow | $-4.6B | $-4.4B | $-5.4B | $-3.1B | — | — | — | $-5.0B |